Investors Snatch XENE Even Cheaper Than Its Secondary Stock Offering
October 19, 2021 at 16:11 PM EDT
Looking back to 13 days ago, Xenon Pharmaceuticals Inc (XENE) priced a 8,474,577 share secondary stock offering at $29.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..